Spain's INGESA (Instituto Nacional de Gestion Sanitaria) dishes out Euro150 million medtech boost
This article was originally published in Clinica
Executive Summary
Spain's national healthcare management institute - Instituto Nacional de Gestion Sanitaria (INGESA) - is already making its mark, after taking over some of the responsibilities of the now defunct Insalud in the newly devolved healthcare system. INGESA was established on August 2 2002, under Royal Decree 840/2002, which defines the restructuring of the Spanish ministry of health and consumer affairs. The institute is responsible for overseeing healthcare under the reformed Servicio Nacional de Salud (SNS) in the devolved regions and for providing the service in the African enclaves of Ceuta and Melilla.
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.